Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-26Clinical Trial Update: The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder [Phase 2]
Phase 2 trial assessing the efficacy and safety of a phosphatidylserine-omega-3 supplement in children with attention-deficit/hyperactivity …
-
CLINICAL_TRIALS trial_result · 2010-02-23Clinical Trial Update: Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]
Phase 3 trial updates on lisdexamfetamine dimesylate (LDX) for adolescents with ADHD, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2010-02-23Clinical Trial Update: Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]
Open-label, multicentre Phase 3 extension study assessing the safety of prolonged-release OROS methylphenidate in adults with attention defi…
-
CLINICAL_TRIALS trial_result · 2010-02-12Clinical Trial Update: Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany [Phase 4]
Phase 4 trial in Germany comparing atomoxetine with placebo in children and adolescents with ADHD and comorbid Oppositional Defiant Disorder…
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 3]
Phase 3 trial update on lisdexamfetamine dimesylate in adults with ADHD; study completed with results posted in 2010.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]
This Phase 3 trial assesses the efficacy and safety of atomoxetine in children with a recent ADHD diagnosis; results have been posted after …
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: Transcranial Magnetic Stimulation in Children With Attention Deficit Hyperactivity Disorder (ADHD). A Safety Study [Phase 1]
This is a Phase 1 safety study evaluating transcranial magnetic stimulation in children with Attention Deficit Hyperactivity Disorder.
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD). [Phase 3]
Phase 3 Italian study evaluating the efficacy of atomoxetine for children and adolescents with attention-deficit/hyperactivity disorder and …
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD [Phase 3]
Phase 3 trial results for the Methylphenidate Transdermal System (MTS) in adolescents with ADHD completed, with safety and efficacy data rep…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA [Phase 3]
This document provides a Phase 3 clinical trial update focusing on quality assurance for administering methylphenidate to adults with Attent…
-
CLINICAL_TRIALS trial_result · 2010-01-06Clinical Trial Update: Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]
A Phase 3 trial evaluating atomoxetine for improving psychosocial functioning in children and adolescents with ADHD has completed and posted…
-
CLINICAL_TRIALS trial_result · 2009-12-31Clinical Trial Update: A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine [Phase 4]
A Phase 4 clinical trial evaluated atomoxetine (Strattera) for Attention Deficit Hyperactivity Disorder. Results were posted on 2009-12-31 b…
-
CLINICAL_TRIALS trial_result · 2009-12-30Clinical Trial Update: The Effect of Methylphenidate on Decision-making Ability of Attention Deficit Hyperactivity Disorder (ADHD) Adults [Phase 1]
A Phase 1 trial assessing the effect of methylphenidate on decision-making in adults with Attention Deficit Hyperactivity Disorder has been …
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 trial update for atomoxetine in adults with Attention-Deficit/Hyperactivity Disorder. Results were posted in December 2009.
-
FDA approval · 2009-12-15FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
FDA approved a supplemental application for the Methylphenidate Transdermal System by PADAGIS US LLC.
-
CLINICAL_TRIALS trial_result · 2009-12-14Clinical Trial Update: Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]
Phase 3 trial evaluating atomoxetine for Attention Deficit Hyperactivity Disorder in Korean children and adolescents. The study is completed…
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms [Phase 3]
Phase 3 trial update for SPD503 (guanfacine hydrochloride) in ADHD with oppositional symptoms; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17 [Phase 3]
Phase 3 study evaluating SPD503 for ADHD in children 6-17 has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 clinical trial update on safety and tolerability of SPD503 and psychostimulants in children and adolescents with ADHD; results compl…
-
FDA approval · 2009-11-04FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved Janssen's supplemental application for CONCERTA (methylphenidate hydrochloride).
-
CLINICAL_TRIALS trial_result · 2009-10-30Clinical Trial Update: An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
The document reports the completion of a Phase 2 exploratory trial of AZD3480 (TC-1734) for adult attention-deficit/hyperactivity disorder. …
-
FDA approval · 2009-10-23FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for FOCALIN XR (dexmethylphenidate hydrochloride) by Sandoz Inc. The approval updates the existing N…
-
CLINICAL_TRIALS research · 2009-10-23Clinical Trial Update: Juvenile Bipolar Disorder Outpatient Program [Phase 4]
Phase 4 juvenile bipolar disorder outpatient trial update; current status is unknown for the study involving bipolar disorder and attention-…
-
CLINICAL_TRIALS trial_result · 2009-10-15Clinical Trial Update: Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 [Phase 3]
Phase 3 trial update on SPD503 for ADHD in children and adolescents shows results and completion.
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 [Phase 2]
Phase 2 clinical trial update on SPD503 for treating ADHD in children 6-17, reporting safety, tolerability, and efficacy.